Office of Medical Communications

(SEPTEMBER 27, 2024) The American Academy of Pediatrics’ AAP News announced that Lewis First, M.D., M.S., has been selected for the Clifford G. Grulee Award and Leah Burke, M.D., M.A., has been honored with the David W. Smith Award for Excellence in Genetics and Birth Defects Education.

(SEPTEMBER 27, 2024) The Burlington Free Press reported on an email sent to patients and “community leaders” on Wednesday by Stephen Leffler, M.D.’90, and other top executives of the UVM Health Network warning that “major reductions” by the Green Mountain Care Board to the Network’s budget for the coming year would result in cuts to care that will directly affect patients.

(SEPTEMBER 24, 2024) Erica Gibson, M.D., associate professor of pediatrics, and Haley McGowan, D.O., assistant professor of psychiatry, were interviewed by WCAX-TV for a story on a renewed push for experts equipped to tackle eating disorders in Vermont.

(SEPTEMBER 20, 2024) Professor of Medicine Jan Carney, M.D., M.P.H., associate dean of public health and health policy, was interviewed by WCAX-TV for a story on toxic metals found in cinnamon.

(SEPTEMBER 20, 2024) Rebecca Bell, M.D., associate professor of pediatrics, was interviewed by WCAX-TV for a story on car seat safety during Child Passenger Safety Week.

(SEPTEMBER 19, 2024) UVM child psychiatrist Steven Schlozman, M.D., associate professor of psychiatry, was interviewed by WCAX-TV for a story about how the national political climate impacts youth mental health.

(SEPTEMBER 19, 2024) Richard Rawson, Ph.D., professor of psychiatry, was quoted in a WBHM story on contingency management as a treatment for addiction to stimulants.

Larner College of Medicine Assistant Professor of Psychiatry and UVM Cancer Center member Elias Klemperer, Ph.D., alongside Co-PI Matthew Carpenter, Ph.D. from the Medical University of South Carolina (MUSC) have received a prestigious R01 grant from the National Institute on Drug Abuse (NIDA).

(SEPTEMBER 17, 2024) In a Vermont Public story on cellphones in schools, Heidi Schumacher, M.D., assistant professor of pediatrics and a member of the American Academy of Pediatrics’ Council on School Health, explains the signs of phone addiction that parents should watch for.

(SEPTEMBER 16, 2024) Anne Morris, M.D., associate professor of family medicine, and Toby Sadkin, M.D., clinical assistant professor of family medicine, commented to VT Digger for a story on Vermont primary care doctors’ contention that low Medicare reimbursement rates make running a primary care practice challenging and results in less access.

(SEPTEMBER 16, 2024) Stephen Leffler, M.D.’90, president and chief operating officer of the UVM Medical Center and professor of emergency medicine at the Larner College of Medicine, spoke with WCAX-TV about the increasing costs of health care in Vermont.

(SEPTEMBER 16, 2024) Steven Roberts, Ph.D., associate professor of microbiology and molecular genetics, and colleagues have developed a new network model to more efficiently identify genetic mutations that work together to drive cancer, Drug Target Review reports.

(SEPTEMBER 13, 2024) Larner Class of 2026 medical student Khadija Moussadek commented to WCAX-TV for a story on a suicide prevention symposium held in Randolph.

This study examined whether e-cigarettes in appealing flavors enhance the decreases in cigarette smoking achieved by reducing the nicotine content of combusted cigarettes to minimally addictive levels.

Assistant Professor of Psychiatry and UVM Cancer Center member Elias Klemperer, Ph.D., and his Co-PI Matthew Carpenter, Ph.D., from the Medical University of South Carolina have received a prestigious R01 grant from the National Institute on Drug Abuse (NIDA). The $3.2 million award will support Klemperer and his team as they conduct a comprehensive study on the dual use of cigarettes and electronic cigarettes.

Sprague's study, “Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort,” published recently in the Annals of Internal Medicine, found that false-positive mammogram results are discouraging many women from returning for important follow-up screenings. Researchers say the additional imaging or biopsies performed after a suspicious finding often cause significant anxiety.